Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Jean-Pierre_Sommadossi
|
| gptkbp:collaboratesWith |
gptkb:Roche
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
infectious diseases
antiviral therapeutics |
| gptkbp:foundedYear |
2012
|
| gptkbp:founder |
gptkb:Jean-Pierre_Sommadossi
|
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Atea Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableProduct |
gptkb:AT-527
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:AVIR
|
| gptkbp:website |
https://ateapharma.com/
|
| gptkbp:bfsParent |
gptkb:Jean-Pierre_Sommadossi
|
| gptkbp:bfsLayer |
7
|